We use corporate social media accounts for sharing information about Actavis Pharmaceuticals globally and in countries where we operate, and they are managed by the Corporate Communications team on Teva’s behalf.
These social accounts are primarily for discussing news, events, social impact and other related topics, as well as employee, patient and caregiver stories. We are excited to interact with you on social channels, and look forward to fruitful and engaging dialogue.
These social channels are not a forum to discuss products, treatments or conditions, or as a venue for reporting adverse events or side effects.
If you have a specific question about our products or services, please use the contact form
to submit a query.
If you are reporting an adverse event or side effect relating to one of our products, please contact Safety.AE@teva.co.il
to learn how Actavis ensures patient safety and privacy. If you are having a life-threatening emergency, please contact your physician or seek local emergency assistance.
We welcome your interactions, and we’ll try to reply to questions in a timely manner. Due to the limitations of these social channels and the regulated nature of the pharmaceutical industry, our replies may be brief. When possible, we will try to direct you to additional relevant information or support.
Actavis’s global social accounts will be regularly monitored and updated Monday to Friday from 9:00 am to 9:00 pm. For any urgent questions or issues, please contact the Actavis Customer Service team in your country or submit a query through our website.
Social channels may occasionally be unavailable and we accept no responsibility for lack of service due to the channel platform’s downtime.
When interacting with Actavis on social channels, we encourage you to be respectful and polite; and to avoid sharing fraudulent, personally identifying, or confidential content. We will not respond to foul language; disparaging, defamatory, or inflammatory comments; or topics unrelated to Actavis.
We will not share specific information about our products or treatments on our social media channels, unless initiated and approved by corporate communications. For product-related information, please visit the relevant Actavis country website in your region to learn more or submit a question through our corporate website:
We cannot comment on or respond to issues related to legal and financial matters, regulatory issues, or proprietary information on social channels.
We may provide links to independent third-party sites in posts and tweets. Actavis has no way of controlling the content of third-party sites, nor does Actavis endorse, or is Actavis responsible for, the content on third-party sites.
Actavis does not endorse, and is not responsible for, the content of any social accounts that the Actavis social accounts follow.